作者
David C Grossman, Susan J Curry, Douglas K Owens, Kirsten Bibbins-Domingo, Aaron B Caughey, Karina W Davidson, Chyke A Doubeni, Mark Ebell, John W Epling, Alex R Kemper, Alex H Krist, Martha Kubik, C Seth Landefeld, Carol M Mangione, Michael Silverstein, Melissa A Simon, Albert L Siu, Chien-Wen Tseng, US Preventive Services Task Force
发表日期
2018/5/8
期刊
Jama
卷号
319
期号
18
页码范围
1901-1913
出版商
American Medical Association
简介
Importance
In the United States, the lifetime risk of being diagnosed with prostate cancer is approximately 11%, and the lifetime risk of dying of prostate cancer is 2.5%. The median age of death from prostate cancer is 80 years. Many men with prostate cancer never experience symptoms and, without screening, would never know they have the disease. African American men and men with a family history of prostate cancer have an increased risk of prostate cancer compared with other men.
Objective
To update the 2012 US Preventive Services Task Force (USPSTF) recommendation on prostate-specific antigen (PSA)–based screening for prostate cancer.
Evidence Review
The USPSTF reviewed the evidence on the benefits and harms of PSA-based screening for prostate cancer and subsequent treatment of screen-detected prostate cancer. The USPSTF also commissioned a review of existing decision analysis …
学术搜索中的文章
DC Grossman, SJ Curry, DK Owens… - Jama, 2018